CDK18
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
cyclin dependent kinase 18 | MIM:169190 | Ensembl:ENSG00000117266 | HGNC:HGNC:8751 | PA33097 | 1q32.1 |
GO terms in CDK18
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | ND | GO:0005575 | cellular_component |
CC | IBA | GO:0005634 | nucleus |
CC | IBA | GO:0005737 | cytoplasm |
BP | IBA | GO:0006468 | protein phosphorylation |
MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
MF | IBA | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
Gene expression in normal tissue: CDK18
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CDK18
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD147 | Prima-1 | 3 |
iGMDRD524 | ISX-9 | 3 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD887 | Compound 23 citrate | 2 |
iGMDRD872 | BRD7137 | 2 |
iGMDRD577 | BIX01294 | 3 |
iGMDRD562 | Navitoclax | 3 |
iGMDRD780 | PP-30 | 2 |
iGMDRD289 | Parthenolide | 5 |
iGMDRD481 | Dactolisib | 3 |
iGMDRD474 | Avrainvillamide | 2 |
iGMDRD137 | Indisulam | 2 |
iGMDRD255 | SB225002 | 3 |
iGMDRD211 | (1S,3R)-RSL3 | 1 |
iGMDRD466 | Chaetocin | 3 |
iGMDRD634 | SCHEMBL2608041 | 2 |
iGMDRD511 | CHEMBL399379 | 3 |
iGMDRD154 | NSC23766 | 3 |
iGMDRD945 | ML214 | 3 |
iGMDRD446 | LY 2183240 | 2 |
iGMDRD85 | Ursolic acid | 3 |
iGMDRD163 | all trans Retinoic Acid | 3 |
iGMDRD150 | RITA | 1 |
iGMDRD427 | ABT737 | 3 |
iGMDRD483 | SCH-529074 | 6 |
iGMDRD523 | Cyanoquinoline, 11 | 3 |
iGMDRD781 | Sirolimus | 2 |
iGMDRD126 | Tipifarnib | 5 |
iGMDRD307 | Manumycin A | 3 |
iGMDRD210 | AC55649 | 1 |
iGMDRD889 | Compound 7d-cis | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CDK18